BLOG

Efek Neuroprotektor Kunyit pada Pasien Alzheimer

29 Oktober 2022

Abstract

Penelitian dan Penulisan dilakukan oleh Rika Mutiara Gemiralda, Marlaokta Marlaokta

Alzheimer merupakan penyakit neurogeneratif kronis progresif. Penyakit ini ditandai dengan gangguan fungsi luhur seperti bahasa, kalkulasi, kapasitas belajar dan sulit mengambil keputusan. ‘Pikun’ merupakan istilah yang digunakan masyarakat untuk menggambarkan penyakit ini. Kehilangan memori jangka pendek merupakan kekhasan dari penyakit ini yang menyebabkan penurunkan produktivitas. Alzheimer sering terjadi pada usia > 65 tahun dan juga ditemukan pada sekitar usia 40 tahun. Kunyit (Curcuma longa L.) merupakan tanaman yang berfungsi sebagai neuroprotektor karena dapat menghambat Protein Tau, akivitas asetilkolinesterase dan berfungsi sebagai anti agregasi Aβ dan β secretase inhibitor. Literature review ini bertujuan untuk menjelaskan gambaran efek neuroprotektor pada kunyit terhadap pasien Alzheimer yang sudah dilakukan oleh peneliti sebelumnya. Metode yang digunakan dalam artikel ini adalah penelusuran artikel melalui database NCBI dan Google Scholar. Tahun penerbitan sumber pustaka adalah dari tahun 2001 sampai 2019 dengan 32 sumber pustaka.Tema dalam artikel yang dikumpulkan yaitu terkait gambaran efek neuroprotektor kunyit terhadap pasien Alzheimer. Hasil dari sintesa artikel yang telah ditemukan yaitu kunyit dapat mencegah penurunan kognitif pada pasien Alzheimer.

Link tautan dan PDF

DOI: https://doi.org/10.32584/jikj.v2i3.431

References

Alloza, M. G., Borrelli, L. A., Rozkalne, A., Hyman, B. T., & Bacskai, B. J. (2007). Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. Journal OfNeurochemistry, 102, 1095–1104. https://doi.org/10.1111/j.1471-4159.2007.04613.x

Alzheimer’s Association. (2007). Alzheimer’s Disease Facts and Figures. Retrieved from https://www.alz.org/national/documents/Report_2007FactsAndFigures.pdf

Baum, L., & Ng, A. (2004). Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer’s disease animal models. Journal of Alzheimer’s Disease, 6, 367–377. https://doi.org/10.3233/jad-2004-6403

Chattopadhyay, I., Biswas, K., Bandyopadhyay, U., & Banerjee, R. K. (2004). Turmeric and curcumin : Biological actions and medicinal applications. CURRENT SCIENCE, 87(1), 44–53.

Clodomiro, A., Gareri, P., Puccio, G., Frangipane, F., Lacava, R., Castagna, A., … Cecilia, A. (2013). Somatic comorbidities and Alzheimer ’ s disease treatment, 1581–1589. https://doi.org/10.1007/s10072-013-1290-3

Cole, G. M., Teter, B., & Frautschy, S. A. (2007). NEUROPROTECTIVE EFFECTS OF CURCUMIN. Adv Exp Med Biol, 595, 197–212.

Fiala, M., Liu, P. T., Espinosa-jeffrey, A., Rosenthal, M. J., Bernard, G., Ringman, J. M., … Cashman, J. (2007). Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer’s disease patients are improved by bisdemethoxycurcumin. PNAS, 104(31), 12849–12854. https://doi.org/10.1073/pnas.0701267104

Goozee, K. G. (2013). McCusker KARVIAH: Curcumin in Alzheimer’s disease prevention. Retrieved from https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12613000681752.

Hamaguchi, T., Ono, K., & Yamada, M. (2010). Curcumin and Alzheimer ’ s Disease, 16, 285–297. https://doi.org/10.1111/j.1755-5949.2010.00147.x

Hishikawa, N., Takahashi, Y., Amakusa, Y., Tanno, Y., & Tuji, Y. (2012). Effects of turmeric on Alzheimer ’ s disease with behavioral and psychological symptoms of dementia. AYU, 33(4), 499–504. https://doi.org/10.4103/0974-8520.110524

Jiang, J., Wang, W., Sun, Y. J., Hu, M., Li, F., & Zhu, D. Y. (2007). Neuroprotective effect of curcumin on focal cerebral ischemic rats by preventing blood – brain barrier damage. European Journal of Pharmacology, 561, 54–62. https://doi.org/10.1016/j.ejphar.2006.12.028

Kementerian Kesehatan RI. (2016). Peran Keluarga Dukung Kesehatan Masyarakat. Kementrian Kesehatan RI, 1–2. Retrieved from http://www.depkes.go.id/article/print/16100700005/peran-keluarga-dukung-kesehatan-jiwa-masyarakat.html

Kementerian Kesehatan RI. (2018). Lansia Sejahtera, Masyarakat Bahagia. Kementerian Kesehatan RI, 1–2. Retrieved from www.depkes.go.id/article/view/18050900001/lansia-sejahtera masyarakat%0A bahagia-.html%0A

Kennedy, R. E., Cutter, G. R., Fowler, M. E., & Schneider, L. S. (2018). Association of Concomitant Use of Cholinesterase Inhibitors or Memantine With Cognitive Decline in Alzheimer Clinical Trials, 1(7), 1–10. https://doi.org/10.1001/jamanetworkopen.2018.4080

Kim, D. S. H. L., Park, S., & Kim, J. (2001). Curcuminoids from Curcuma longa L. (Zingiberaceae) that protect PC12 rat pheochromocytoma and normal human umbilical vein endothelial cells from betaA (1-42) insult. Neuroscience Letters, 303, 57–61. https://doi.org/10.1016/s0304-3940(01)01677-9

Kumar, A., & Tsao, J. W. (2019). Alzheimer Disease. StatPearls Publishing. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK499922/

Lao, C. D., Iv, M. T. R., Normolle, D., Heath, D. D., Murray, S. I., Bailey, J. M., … Brenner, D. E. (2006). BMC Complementary and Dose escalation of a curcuminoid formulation. BMC Complementary and Alternative Medicine, 6(10), 4–7. https://doi.org/10.1186/1472-6882-6-10

Lewis, J., Lewis, J., Dickson, D. W., Lin, W., Chisholm, L., Corral, A., … Mcgowan, E. (2001). Enhanced Neurofibrillary Degeneration in Transgenic Mice Expressing Mutant Tau and APP. SCIENCE, 293, 1487–1491. https://doi.org/10.1126/science.1058189

Lin, R., Chen, X., Li, W., Han, Y., Liu, P., & Pi, R. (2008). Neuroscience Letters Exposure to metal ions regulates mRNA levels of APP and BACE1 in PC12 cells : Blockage by curcumin. Neuroscience Letters, 440, 344–347. https://doi.org/10.1016/j.neulet.2008.05.070

Ma, Q., Yang, F., Rosario, E. R., Ubeda, O. J., Beech, W., Gant, D. J., … Cole, G. M. (2009). ␤ -Amyloid Oligomers Induce Phosphorylation of Tau and Inactivation of Insulin Receptor Substrate via c-Jun N-Terminal Kinase Signaling : Suppression by Omega-3 Fatty Acids and Curcumin, 29(28), 9078–9089. https://doi.org/10.1523/JNEUROSCI.1071-09.2009

Noviria, M., Triyoso, & Yanti, L. (2014). HUBUNGAN DUKUNGAN KELUARGA DENGAN KUNJUNGAN KONTROLPASIEN JIWA. JURNAL KESEHATAN HOLISTIK, 8(2), 76–81.

Ono, K., Hasegawa, K., Naiki, H., & Yamada, M. (2004). Curcumin Has Potent Anti-Amyloidogenic Effects for Alzheimer ’ s ␤ -Amyloid Fibrils In Vitro, 750, 742–750.

Park, S., & Kim, D. S. H. L. (2002). Discovery of Natural Products from Curcuma longa that Protect Cells from Beta-Amyloid Insult : A Drug Discovery Effort against Alzheimer’s Disease. Journal of Natural Products, 65(9), 1227–1231. https://doi.org/10.1021/np010039x

Reddy, P. H., Manczak, M., & Mitchell, A. (2018). HHS Public Access Author manuscript, (October). https://doi.org/10.3233/JAD-170512

Shukla, P. K., Khanna, V. K., Khan, M. Y., & Srimal, R. C. (2003). Protective effect of curcumin against lead neurotoxicity in rat. Human & Experimental Toxicology, 22, 653–658. https://doi.org/10.1191/0960327103ht411oa

Valasani, K. R., Sun, Q., Hu, G., Li, J., Du, F., & Guo, Y. (2014). Identification of Human ABAD Inhibitors for Rescuing Aβ- Mediated Mitochondrial Dysfunction. Curr Alzheimer Res, 11(2), 128–136. https://doi.org/10.2174/1567205011666140130150108

Videbeck, S. L. (2008). Buku Ajar Keperawatan Jiwa. Jakarta: EGC.

Villaflores, O. B., Chen, Y., Chen, C., & Yeh, J. (2012). Curcuminoids and resveratrol as anti-Alzheimer agents. Taiwanese Journal of Obstetrics & Gynecology, 51(4), 515–525. https://doi.org/10.1016/j.tjog.2012.09.005

Yang, F., Lim, G. P., Aynun, N., Ubeda, O. J., Mychica, R., Ambegaokar, S. S., … Cole, G. M. (2005). Protein Structure and Folding : Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils , Binds Plaques , and Reduces Amyloid in Vivo Curcumin Inhibits Formation of Amyloid ␤ Oligomers and Fibrils , Binds Plaques , and Reduces Amyloid in Vivo *. https://doi.org/10.1074/jbc.M404751200

Zhang, L., Fang, Y., Xu, Y., Lian, Y., Xie, N., & Wu, T. (2015). Curcumin Improves Amyloid β -Peptide ( 1-42 ) Induced Spatial Memory Deficits through BDNF-ERK Signaling Pathway, 1–17. https://doi.org/10.1371/journal.pone.0131525

JURNAL PENELITIAN TERKAIT ARTIKEL